Ladenburg Thalmann Financial Services’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $14K | Buy |
272
+203
| +294% | +$10.4K | ﹤0.01% | 4309 |
|
2019
Q3 | $4K | Buy |
+69
| New | +$4K | ﹤0.01% | 4746 |
|
2019
Q2 | – | Sell |
-180
| Closed | -$5K | – | 5257 |
|
2019
Q1 | $5K | Sell |
180
-75
| -29% | -$2.08K | ﹤0.01% | 4632 |
|
2018
Q4 | $9K | Sell |
255
-262
| -51% | -$9.25K | ﹤0.01% | 4316 |
|
2018
Q3 | $22K | Sell |
517
-483
| -48% | -$20.6K | ﹤0.01% | 3841 |
|
2018
Q2 | $50K | Hold |
1,000
| – | – | ﹤0.01% | 3239 |
|
2018
Q1 | $50K | Sell |
1,000
-2,819
| -74% | -$141K | ﹤0.01% | 3239 |
|
2017
Q4 | $206K | Sell |
3,819
-2,375
| -38% | -$128K | ﹤0.01% | 2196 |
|
2017
Q3 | $359K | Buy |
6,194
+4,993
| +416% | +$289K | ﹤0.01% | 1676 |
|
2017
Q2 | $59K | Sell |
1,201
-14
| -1% | -$688 | ﹤0.01% | 2906 |
|
2017
Q1 | $53K | Sell |
1,215
-2,597
| -68% | -$113K | ﹤0.01% | 2857 |
|
2016
Q4 | $187K | Buy |
3,812
+2,432
| +176% | +$119K | ﹤0.01% | 1865 |
|
2016
Q3 | $66K | Sell |
1,380
-4,076
| -75% | -$195K | ﹤0.01% | 2566 |
|
2016
Q2 | $293K | Buy |
5,456
+80
| +1% | +$4.3K | ﹤0.01% | 1428 |
|
2016
Q1 | $240K | Buy |
5,376
+4,420
| +462% | +$197K | ﹤0.01% | 1484 |
|
2015
Q4 | $37K | Buy |
956
+106
| +12% | +$4.1K | ﹤0.01% | 2786 |
|
2015
Q3 | $28K | Hold |
850
| – | – | ﹤0.01% | 2869 |
|
2015
Q2 | $28K | Buy |
850
+50
| +6% | +$1.65K | ﹤0.01% | 3002 |
|
2015
Q1 | $33K | Hold |
800
| – | – | ﹤0.01% | 2856 |
|
2014
Q4 | $32K | Sell |
800
-3,400
| -81% | -$136K | ﹤0.01% | 2658 |
|
2014
Q3 | $154K | Sell |
4,200
-1,600
| -28% | -$58.7K | ﹤0.01% | 1357 |
|
2014
Q2 | $269K | Hold |
5,800
| – | – | 0.01% | 1044 |
|
2014
Q1 | $238K | Hold |
5,800
| – | – | 0.01% | 1044 |
|
2013
Q4 | $221K | Buy |
5,800
+5,050
| +673% | +$192K | 0.01% | 1028 |
|
2013
Q3 | $18K | Buy |
+750
| New | +$18K | ﹤0.01% | 2512 |
|